Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. airway disease
Show results for
Products

Companies

News
Articles
Downloads

Refine by
Date

  • Older

Airway Disease Articles & Analysis

16 news found

Understanding Lung Biomechanics In Asthma By Combining ex vivo with in vivo

Understanding Lung Biomechanics In Asthma By Combining ex vivo with in vivo

Asthma remains a complex and multifactorial disease, with airway hyperresponsiveness to methacholine being a hallmark feature. ...

BySCIREQ - an emka TECHNOLOGIES Company


Prof. Krestin Joins Fluidda’S Board of Directors

Prof. Krestin Joins Fluidda’S Board of Directors

For example, it is possible to quantify diseases of the airways and at the same time disturbances in the blood flow. ...

ByFluidda


VIDA Introduces New AI-Enabled Biomarker Services

VIDA Introduces New AI-Enabled Biomarker Services

These latest imaging biomarkers strengthen VIDA’s portfolio of airway, tissue, vascular and functional measures. VIDA’s latest airway biomarkers include mucus plug scoring, bronchiectasis scoring, and total airway count (TAC). ...

ByVIDA Diagnostics Inc.


Valeo Pharma Obtains Public Reimbursement For Enerzair® Breezhaler® And Atectura® Breezhaler® In Quebec And Nova Scotia

Valeo Pharma Obtains Public Reimbursement For Enerzair® Breezhaler® And Atectura® Breezhaler® In Quebec And Nova Scotia

About Atectura® Breezhaler® Atectura® Breezhaler® is indicated as a once-daily maintenance treatment of asthma in adults and adolescents 12 years of age and older with reversible obstructive airways disease. Atectura® Breezhaler® should be prescribed for patients not adequately controlled on a long-term asthma control medication, such as ...

ByValeo Pharma Inc.


Valeo Pharma Obtains Public Reimbursement For Enerzair® Breezhaler® And Atectura® Breezhaler® In Alberta

Valeo Pharma Obtains Public Reimbursement For Enerzair® Breezhaler® And Atectura® Breezhaler® In Alberta

About Atectura® Breezhaler® Atectura® Breezhaler® is indicated as a once-daily maintenance treatment of asthma in adults and adolescents 12 years of age and older with reversible obstructive airways disease. Atectura® Breezhaler® should be prescribed for patients not adequately controlled on a long-term asthma control medication, such ...

ByValeo Pharma Inc.


AioCare system could be successfully applied in primary healthcare Centers.

AioCare system could be successfully applied in primary healthcare Centers.

The role of spirometry in diagnosing and monitoring chronic obstructive airway diseases is crucial. According to WHO, the demonstration of irreversible airway obstruction is essential for diagnosing chronic obstructive pulmonary disease (COPD), which is the third leading cause of death worldwide. ...

ByAioCare


Stemedica Signs License Agreement with Pulthera, LLC for all Respiratory Indications including those related to COVID-19

Stemedica Signs License Agreement with Pulthera, LLC for all Respiratory Indications including those related to COVID-19

Stemedica’s Licensing Agreement with Pulthera is for the diagnosis, prevention and/or treatment of COVID-19 and complications thereof and for lung, pulmonary and respiratory conditions including, but not limited to, ARDS, Asthma, Bronchitis, COPD, Cystic Fibrosis, Emphysema, Pleural Effusion, Pneumonia, Pulmonary Fibrosis, and Reactive Airway Disease on a ...

ByStemedica Cell Technologies, Inc.


Arab Health 2020

Arab Health 2020

The line we are dealing with is linked with Airway Management and the Respiratory diseases. We were to present our three core products i.e. ...

ByBeijing Yaguo Technology Co., Ltd.


Feldan therapeutics announces a publication in nature communications

Feldan therapeutics announces a publication in nature communications

Paul McCray, from the University of Iowa Carver College of Medicine, demonstrate that Feldan’s engineered amphiphilic peptides (Feldan Shuttles) allow safe and efficient intracellular delivery of proteins to airway epithelia. The authors declare: "The delivery of biologic cargoes to airway epithelial cells is challenging due to the formidable barriers ...

ByFeldan Therapeutics


Abionic Signs Agreement to Optimize Asthma Management in the U.S. through Innovative Rapid Point-of-Care Tests

Abionic Signs Agreement to Optimize Asthma Management in the U.S. through Innovative Rapid Point-of-Care Tests

The agreement with Genentech, a leader in developing novel medicines in respiratory diseases including allergic asthma, is a great step towards more personalized and precise diagnostics,” commented Nicolas Durand, PhD, Chief Executive Officer of Abionic. ...

ByAbionic SA


Sommetrics Selected to Present at the Respiratory Innovation Summit

Sommetrics Selected to Present at the Respiratory Innovation Summit

This Summit is a yearly event held in advance of the American Thoracic Society’s International meeting which brings together clinicians, innovators and investors focused on new approaches for treating widespread and crippling lung and airway diseases. “This is an ideal venue for highlighting the clinical progress made in establishing our ...

BySommetrics


Flu virus is protected by mucus when airborne, regardless of humidity

Flu virus is protected by mucus when airborne, regardless of humidity

Mucus and other airway secretions surrounding influenza viruses when coughed or exhaled from infected individuals may protect the virus in the aerosol phase, even in high humidity environments. ...

ByThe Aerosol Society


Identifying Asthma Triggers and Managing the Condition in the Nation’s Schools

Identifying Asthma Triggers and Managing the Condition in the Nation’s Schools

In 2013, students missed 13.8 million school days due to asthma, making the disease a leading cause of school absenteeism according to the Centers for Disease Control and Prevention (CDC). ...

ByCochrane & Associates, LLC


£1 million investment for CRACK IT Challenge

£1 million investment for CRACK IT Challenge

Led by King's College London and also involving the University of Hertfordshire, the Inhalation Translation Challenge aims to help reduce the number of animals used to test medicines for treating inflammatory diseases of the airways such as asthma. Following a successful proof-of-concept study (Phase 1) and a 'Dragons' Den' style interview process, the project ...

ByNational Physical Laboratory (NPL)


Are Chicago’s Urban Youth at a Higher Risk of Developing Asthma?

Are Chicago’s Urban Youth at a Higher Risk of Developing Asthma?

The article stated, “…researchers suspect that it's the diversity of exposure to different microbes that may offer protection against the airway disease.” The Centers for Disease Control and Prevention (CDC) reports, “Asthma is a disease that affects your lungs. ...

ByCochrane & Associates, LLC


Asthma and the Link to Exposure to Mold and Bacteria

Asthma and the Link to Exposure to Mold and Bacteria

In February of this year it was reported in HealthDay News that, “The risk of asthma was reduced by as much as 51 percent for children living on farms, and researchers suspect that it's the diversity of exposure to different microbes that may offer protection against the airway disease.” Asthma attacks create an inflammation of the lungs and ...

ByCochrane & Associates, LLC

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT